Operation Warp Speed Shortlist Not Decided Yet, Says Novavax
We’re Still In The Running, Says R&D Chief
Novavax gained a US Department of Defense contract for its vaccine candidate recently, and is confident its nanoparticle approach provides a good alternative to other technologies.
You may also be interested in...
Novavax has progressed into Phase I trials with relatively little funding, but backing from Operation Warp Speed makes it a stronger contender.
Several countries already are calling about orders, as the company prepares to begin a Phase III trial of its mRNA coronavirus vaccine candidate.
Join us for a quick audio roundup of five useful things to know from Scrip's recent coverage of the global biopharma industry.